Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

I’m getting the feeling there’s going to be

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (7) | Next 10 | Previous | Next
Irishvox Member Profile
 
Followed By 13
Posts 762
Boards Moderated 0
Alias Born 03/07/18
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 1/10/2022 5:13:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/5/2022 5:16:52 PM
CytoDyn's leronlimab in 350 mg weekly dose met endpoints in Phase 2 NASH trial Seeking Alpha - 1/5/2022 9:38:39 AM
IQST - $0.60 Sleeper Stock Set To Explode In Fintech Parade Of Decacorn IPO's InvestorsHub NewsWire - 12/23/2021 11:51:16 AM
CytoDyn receives positive response from FDA for Phase 3 leronlimab study in COVID-19 Seeking Alpha - 12/21/2021 9:28:46 AM
CytoDyn files for expanded access use of leronlimab for HIV patients Seeking Alpha - 12/9/2021 9:13:36 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 11/30/2021 6:32:42 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 11/30/2021 6:32:41 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 11/30/2021 6:31:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/29/2021 6:30:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/29/2021 6:27:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/29/2021 6:20:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/24/2021 5:22:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/24/2021 4:05:01 PM
CytoDyn reports leronlimab data in NASH trial for first 15 patients Seeking Alpha - 11/24/2021 10:08:44 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/23/2021 5:24:15 PM
SA Breaking News - PURA estimates $1M in 2022 revenue InvestorsHub NewsWire - 11/22/2021 9:38:18 AM
PURA BULLISH RESURGANCE InvestorsHub NewsWire - 11/19/2021 8:50:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/17/2021 6:02:41 AM
CytoDyn submits the first section of HIV BLA to FDA under rolling review Seeking Alpha - 11/16/2021 7:07:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2021 4:55:20 PM
CytoDyn submits leronlimab Breakthrough Therapy designation application to the FDA Seeking Alpha - 11/8/2021 7:50:43 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/5/2021 11:30:49 AM
CytoDyn posts preliminary results from mid-stage leronlimab NASH study Seeking Alpha - 11/3/2021 6:11:13 AM
iQSTEL, Inc. - The Calm Before The Surge (OTCQX: IQST) InvestorsHub NewsWire - 10/29/2021 2:31:48 PM
Irishvox   Monday, 04/05/21 08:52:25 PM
Re: None
Post # of 201022 
I’m getting the feeling there’s going to be a concerted effort to push the stock down first thing in the morning in an attempt to cover and accumulate… I think a fair amount of buying the past week could’ve been shorts loading up for such an event. I think when Clay trader shows up on the board it’s a signal and when he talks about $3.50 being the first level of support it’s a goal for his followers

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (7) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences